RECORD // Company

Corvus Pharmaceuticals, Inc.

Built 2026-11-21T11:27:46Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Matched by name only, not merged (4)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Corvus Pharmaceuticals, Inc. · Ctgov · same registered legal name as 'Corvus Pharmaceuticals, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CORVUS PHARMACEUTICALS INC · Epa echo · same registered legal name as 'Corvus Pharmaceuticals, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CORVUS PHARMACEUTICALS INC · Epa echo · same registered legal name as 'Corvus Pharmaceuticals, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CORVUS PHARMACEUTICALS INC · Epa echo · same registered legal name as 'Corvus Pharmaceuticals, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

2 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-05 · accession 0001104659-26-123317

ItemValuePeriodFormFiledAccessionReport
Net income (loss)$-20,343,0003 months ended 2026-09-3010-Q2026-11-050001104659-26-1233172026-11-21 11:27 UTCReport an error
Cash and cash equivalents$15,013,000at 2026-09-3010-Q2026-11-050001104659-26-1233172026-11-21 11:27 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Revenue, Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001626971
Ticker
CRVS
EIN
464670809
CUSIP
221015100
Record ID
sx:sec:0001626971

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

29 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-13SEC EDGAR company profile2026-11-21 11:27 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-13SEC EDGAR company profile2026-11-21 11:27 UTCReport an error
State of incorporationDE2026-11-13SEC EDGAR company profile2026-11-21 11:27 UTCReport an error
Fiscal year end (MMDD)12312026-11-13SEC EDGAR company profile2026-11-21 11:27 UTCReport an error
Business address901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 940802026-11-13SEC EDGAR company profile2026-11-21 11:27 UTCReport an error
ExchangesNasdaq2026-11-13SEC EDGAR company profile2026-11-21 11:27 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-15,283,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-21 11:27 UTCReport an error
Total assets (at 2025-12-31)$71,119,0002025-12-3110-K, XBRL Assets2026-11-21 11:27 UTCReport an error
Stockholders' equity (at 2025-12-31)$61,205,0002025-12-3110-K, XBRL StockholdersEquity2026-11-21 11:27 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$4,576,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 11:27 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-32,797,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:27 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$174,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 11:27 UTCReport an error
Form D total offering amount (D filed 2015-09-25)$74,999,9012015-09-25D2026-11-21 11:27 UTCReport an error
Form D total amount sold (D filed 2015-09-25)$74,999,9012015-09-25D2026-11-21 11:27 UTCReport an error
Form D industry groupOther Health Care2015-09-25D2026-11-21 11:27 UTCReport an error
Form D revenue rangeDecline to Disclose2015-09-25D2026-11-21 11:27 UTCReport an error
Form D date of first sale2015-09-162015-09-25D2026-11-21 11:27 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-05)On November 5, 2026, Corvus Pharmaceuticals, Inc. issued a press release regarding, among other matters, its financial results for the three and nine months ended September 30, 2026 and its financial position as of September 30, 2026, and provided a business update. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K. The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as…2026-11-05SEC EDGAR 8-K 0001171843-26-007175 (text as filed, excerpt)2026-11-21 11:27 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-06)On August 6, 2026, Corvus Pharmaceuticals, Inc. issued a press release regarding, among other matters, its financial results for the three and six months ended June 30, 2026 and its financial position as of June 30, 2026, and provided a business update. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K. The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the…2026-08-06SEC EDGAR 8-K 0001171843-26-005317 (text as filed, excerpt)2026-11-21 11:27 UTCReport an error
Largest institutional holder #1 (13F as filed): ORBIMED ADVISORS LLC$107,045,1902026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error
Largest institutional holder #2 (13F as filed): BlackRock, Inc.$106,653,8372026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error
Largest institutional holder #3 (13F as filed): STATE STREET CORP$66,842,9202026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error
Largest institutional holder #4 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$49,193,0872026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error
Largest institutional holder #5 (13F as filed): ADAMS STREET PARTNERS LLC$48,937,7032026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error
Largest institutional holder #6 (13F as filed): Vivo Capital, LLC$41,918,8912026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error
Largest institutional holder #7 (13F as filed): WELLINGTON MANAGEMENT GROUP LLP$40,810,5812026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error
Largest institutional holder #8 (13F as filed): PERCEPTIVE ADVISORS LLC$39,851,5692026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error
Largest institutional holder #9 (13F as filed): Deep Track Capital, LP$37,229,5692026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error
Largest institutional holder #10 (13F as filed): BRAIDWELL LP$31,766,8922026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:27 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.